9/25/2020  6:45:26 PM Chg. -0.570 Volume Bid8:02:59 PM Ask8:02:59 PM Market Capitalization Dividend Y. P/E Ratio
37.810EUR -1.49% 76
Turnover: 2,890.420
37.630Bid Size: 665 38.130Ask Size: 656 21.12 bill.EUR 2.22% 11.21

Business description

Fresenius is a health care group with international operations, providing products and services for dialysis, hospital and outpatient medical care.
 

Management board & Supervisory board

CEO
Stephan Sturm
Management board
Rachel Empey, Dr. Ernst Wastler, Dr. Francesco De Meo, Mats Henriksson, Rice Powell, Sebastian Biedenkopf (ab 1.01.2021)
Supervisory board
Dr. Gerd Krick, Grit Genster, Michael Diekmann, Bernd Behlert, Frauke Lehmann, Hauke Stars, Klaus-Peter Müller, Konrad Kölbl, Oscar Romero De Paco, Prof. Dr. D. Michael Albrecht, Prof. Dr. Iris Löw-Friedrich, Stefanie Balling
 

Company data

Name: Fresenius SE & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-608-0
Fax: -
E-mail: pr-fre@fresenius.com
Internet: www.fresenius.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 54.77%
IPO date: 12/18/1986

Investor relations

Name: Markus Georgi
IR phone: +49-6172-608-2485
IR Fax: +49-6172-608-2488
IR e-mail: ir-fre@fresenius.com

Company calendar

CW 44 | 10/30/2020 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
54.77%
Else Kröner-Fresenius-Stiftung
 
26.60%
Allianz Global Investors GmbH
 
4.98%
BlackRock, Inc.
 
4.74%
Henderson Group plc
 
3.01%
DWS Investment GmbH
 
2.98%
The Capital Group Companies, Inc.
 
2.92%
Others
 
0.00%